RPTX: the cash flow

MyFinsight

For the quarter ending 2025-09-30, RPTX had $5,169K increase in cash & cash equivalents over the period.

Cash Flow	2025-09-30	2025-06-30
Net loss for the period	3,258	-46,787
Share-based compensation expense	1,409	6,047
Depreciation expense	72	2,222
Non-cash lease expense	299	1,295
Foreign exchange gain	-39	117
Net accretion of marketable securities	480	1,006
Gain on sale of technology and other assets	130	5,666
Gain on termination of collaboration agreement	3,257	-
Impairment loss on rou asset	330	-
Prepaid expenses	1,052	-3,006
Other current receivables	-1,463	-67
Other non-current assets	0	-179
Deferred collaboration cost recovery	-	3,257
Accounts payable	-2,667	382
Accrued expenses and other current liabilities	-2,223	-7,652
Operating lease liability, current portion	-302	-1,223
Income taxes	9,149	609
Operating lease liability, net of current portion	0	-88
Deferred revenue	0	0
Net cash used in operating activities	2,651	-45,475
Proceeds from sale of technology and other assets	0	1,000
Proceeds from maturities of marketable securities	10,150	73,662
Purchase of marketable securities	7,613	46,456
Net cash provided by investing activities	2,537	28,206
Proceeds from exercise of stock options	0	0
Proceeds from issuance of common stock under the 2020 employee share purchase plan	30	79
Net cash provided by financing activities	30	79
Effect of exchange rate fluctuations on cash held	-49	129
Net decrease in cash and cash equivalents	5,169	-17,061
Cash and cash equivalents at beginning of period	84,717	-
Cash and cash equivalents at end of period	72,825	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.